We provide you with 20 years of free, institutional-grade data for AGIO stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of AGIO. Explore the full financial landscape of AGIO stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2025-07-31 | 1439222 | AGIO | 10-Q | Url |
| 2025-05-01 | 1439222 | AGIO | 10-Q | Url |
| 2025-02-13 | 1439222 | AGIO | 10-K | Url |
| 2024-10-31 | 1439222 | AGIO | 10-Q | Url |
| 2024-08-01 | 1439222 | AGIO | 10-Q | Url |
| 2024-05-02 | 1439222 | AGIO | 10-Q | Url |
| 2024-02-15 | 1439222 | AGIO | 10-K | Url |
| 2023-11-02 | 1439222 | AGIO | 10-Q | Url |
| 2023-08-03 | 1439222 | AGIO | 10-Q | Url |
| 2023-05-04 | 1439222 | AGIO | 10-Q | Url |
| 2023-02-23 | 1439222 | AGIO | 10-K | Url |
| 2022-11-03 | 1439222 | AGIO | 10-Q | Url |
| 2022-08-04 | 1439222 | AGIO | 10-Q | Url |
| 2022-05-05 | 1439222 | AGIO | 10-Q | Url |
| 2022-02-24 | 1439222 | AGIO | 10-K | Url |
| 2021-11-03 | 1439222 | AGIO | 10-Q | Url |
| 2021-07-29 | 1439222 | AGIO | 10-Q | Url |
| 2021-04-29 | 1439222 | AGIO | 10-Q | Url |
| 2021-02-25 | 1439222 | AGIO | 10-K | Url |
| 2020-11-05 | 1439222 | AGIO | 10-Q | Url |
| 2020-07-30 | 1439222 | AGIO | 10-Q | Url |
| 2020-04-30 | 1439222 | AGIO | 10-Q | Url |
| 2020-02-19 | 1439222 | AGIO | 10-K | Url |
| 2019-10-31 | 1439222 | AGIO | 10-Q | Url |
| 2019-08-01 | 1439222 | AGIO | 10-Q | Url |
| 2019-05-02 | 1439222 | AGIO | 10-Q | Url |
| 2019-02-14 | 1439222 | AGIO | 10-K | Url |
| 2018-11-01 | 1439222 | AGIO | 10-Q | Url |
| 2018-08-02 | 1439222 | AGIO | 10-Q | Url |
| 2018-05-04 | 1439222 | AGIO | 10-Q | Url |
| 2018-02-14 | 1439222 | AGIO | 10-K | Url |
| 2017-11-01 | 1439222 | AGIO | 10-Q | Url |
| 2017-08-08 | 1439222 | AGIO | 10-Q | Url |
| 2017-05-04 | 1439222 | AGIO | 10-Q | Url |
| 2017-02-16 | 1439222 | AGIO | 10-K | Url |
| 2016-11-03 | 1439222 | AGIO | 10-Q | Url |
| 2016-08-08 | 1439222 | AGIO | 10-Q | Url |
| 2016-05-09 | 1439222 | AGIO | 10-Q | Url |
| 2016-02-26 | 1439222 | AGIO | 10-K | Url |
| 2015-11-06 | 1439222 | AGIO | 10-Q | Url |
| 2015-08-07 | 1439222 | AGIO | 10-Q | Url |
| 2015-05-11 | 1439222 | AGIO | 10-Q | Url |
| 2015-02-24 | 1439222 | AGIO | 10-K | Url |
| 2014-11-07 | 1439222 | AGIO | 10-Q | Url |
| 2014-08-07 | 1439222 | AGIO | 10-Q | Url |
| 2014-05-09 | 1439222 | AGIO | 10-Q | Url |
| 2014-04-10 | 1439222 | AGIO | S-1 | Url |
| 2014-03-18 | 1439222 | AGIO | 10-K | Url |
| 2013-11-07 | 1439222 | AGIO | 10-Q | Url |
| 2013-09-05 | 1439222 | AGIO | 10-Q | Url |
| 2013-06-10 | 1439222 | AGIO | S-1 | Url |
Agios Pharmaceuticals, Inc(NASDAQ:AGIO) 
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers TIBSOVO (ivosidenib), an oral targeted inhibitor for treating adult patients with relapsed or refracto...
Website: http://www.agios.com
Founded: 2008
Full Time Employees: 536
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about AGIO stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.